Stocks · News reference
Oppenheimer Upgrades NICE to Outperform, Announces $150 Price Target
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Citizens Maintains Market Outperform on NICE, Lowers Price Target to $158
NICE Ltd. Reports Q3 2026 Financial Results and Announces Workforce Reduction
NICE Ltd. reported Q3 2026 revenue of $790.7 million and announced a 5% workforce reduction as part of a new operating-model efficiency initiative.
Axon Enterprise vs. Monday.com: Which Industrials Stock Is a Better Buy for 2027?
Axon Enterprise and Monday.com represent different investment approaches: Axon commands a premium valuation (P/E 55.7x) with strong 33.5% revenue growth and expanding cloud services in law enforcement, while Monday.com trades at a discount (P/E 17.2x) with slower 26.7% growth but superior cash generation. The article concludes Axon is the better choice for 2027 due to stronger momentum, despite Monday.com's attractive valuation and AI platform expansion.
Ciklum and NICE Partner to Bring Agentic AI to Enterprise Customer Experiences
Ciklum and NICE have announced a strategic technology partnership to help enterprises integrate agentic AI into their customer service operations.
Shares of enterprise software companies are trading higher amid an investor rotation from highly leveraged AI-exposed names into the legacy tech services sector. Fears of persistently high inflation and interest rates may increase the appeal of the industry's proven business models.